ProNAi Therapeutics CEO Nick Glover's 2018 pay jumps 74% to $1.9M
ProNAi Therapeutics reports 2018 executive compensation
By ExecPay News
Published: December 18, 2019
ProNAi Therapeutics reported fiscal year 2018 executive compensation information on December 18, 2019.
In 2018, three executives at ProNAi Therapeutics received on average a compensation package of $1.3M, a 42% increase compared to previous year.
Average pay of disclosed executives at ProNAi Therapeutics
Nick Glover, Chief Executive Officer, received $1.9M in total, which increased by 74% compared to 2017. 51% of Glover's compensation, or $992K, was in option awards. Glover also received $347K in non-equity incentive plan, $579K in salary, as well as $23K in other compensation.
Barbara Klencke, Chief Development Officer, received a compensation package of $969K, which increased by 44% compared to previous year. 48% of the compensation package, or $463K, was in salary.
Sukhi Jagpal, Chief Financial Officer, earned $859K in 2018.
Related executives
You may also like
Source: SEC filing on December 18, 2019.